Mulyantari AI

No ORCID on file · 2 papers in corpus · active 2023-2024
2024
Nomogram development for predicting ovarian tumor malignancy using inflammatory biomarker and CA-125.
Scientific reports ·doi:10.1038/s41598-024-66509-9

Global challenges in ovarian cancer underscore the need for cost-effective screening. This study aims to assess the role of pretreatment Neutrophil-to-Lymphocyte Ratio (NLR), Lymphocyte-to-Monocyte-Ratio (LMR), Platelet-to-Lymphocyte Ratio …

2023
Comparison of glutaminase and cancer antigen 125 for distinguishing benign and malignant ovarian tumors.
Clinical and translational science ·doi:10.1111/cts.13603

Increasing demand for glutaminase (GLS) due to high rates of glutamine metabolism is considered one of the hallmarks of malignancy. In parallel, cancer antigen 125 (CA-125) is a commonly used ovarian tumor marker. This study aimed to compar…